Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

DPEP1 antagonist LSALT shows promise in preclinical models of acute kidney injury

Feb. 9, 2022

Three components enable 3D kidney tissue from mouse embryonic stem cells

Feb. 8, 2022

Targeting NQO1 shows protective effects in models of diabetic nephropathy

Feb. 8, 2022

Anakuria's AT-20494 to be studied for ADPKD and other indications

Feb. 3, 2022

Vertex Pharmaceuticals identifies new APOL1 inhibitors

Jan. 5, 2022

Nephrology

Jan. 1, 2022

Novel XO inhibitors show efficacy in acute hyperuricemia rat model

Dec. 21, 2021

Chinook Therapeutics identifies LDHA inhibitors

Dec. 15, 2021

Chinook Therapeutics divulges LDHA inhibitors

Dec. 13, 2021

Lennham discloses deuterated testosterone compound

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 13, 2025.
Little bite from voluntary most-favored nation Rx pricing order
BioWorld
After a week of hype, the most-favored nation (MFN) drug pricing executive order (EO) U.S. President Donald Trump signed May 12 has a lot of bark but little bite,...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
China’s NMPA gives thumbs up to Remegen’s ADC targeting HER2
BioWorld
China’s National Medical Products Administration has approved Remegen Co. Ltd.’s antibody-drug conjugate (ADC), disitamab vedotin (RC-48), for treatment of...